APA (7th ed.) Citation

Mazzaferro, V., El-Rayes, B. F., Droz dit Busset, M., Cotsoglou, C., Harris, W. P., Damjanov, N., . . . Shaib, W. L. (2019). Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma. British journal of cancer, 120(2), 165-171. https://doi.org/10.1038/s41416-018-0334-0

Chicago Style (17th ed.) Citation

Mazzaferro, Vincenzo, et al. "Derazantinib (ARQ 087) in Advanced or Inoperable FGFR2 Gene Fusion-positive Intrahepatic Cholangiocarcinoma." British Journal of Cancer 120, no. 2 (2019): 165-171. https://doi.org/10.1038/s41416-018-0334-0.

MLA (9th ed.) Citation

Mazzaferro, Vincenzo, et al. "Derazantinib (ARQ 087) in Advanced or Inoperable FGFR2 Gene Fusion-positive Intrahepatic Cholangiocarcinoma." British Journal of Cancer, vol. 120, no. 2, 2019, pp. 165-171, https://doi.org/10.1038/s41416-018-0334-0.